Daxor Corporation announces Launch Tennessee awarded Daxor Corporation a $300K SBIR matching fund to advance its next-generation point-of-care blood volume analyzer, building on Daxor’s Phase II award from the Defense Health Agency. “This award is a welcome addition to Daxor’s long-standing and robust portfolio of non-dilutive funding, which focuses on leveraging public funding to empower clinicians with advanced tools for optimal fluid management to enhance patient outcomes,” said Michael Feldschuh, CEO and President of Daxor. “This award highlights our unwavering commitment to innovation, job creation, and our enduring presence in Oak Ridge. We are proud to be part of the vibrant Tennessee community and grateful for this recognition.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DXR:
- Central Florida hospital implements Daxor BVA-100 blood volume diagnostic
- Leading Central Florida Hospital Implements Daxor’s BVA-100™ Blood Volume Diagnostic for Heart Failure Patient Care
- Daxor CEO says NAV increased to $6.75 p/s from $6.33 last year this time
- Daxor Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference
- Daxor Corporation Announces Launch of BVA Program at Mid-South Largest Integrated Network